Vendor, Rockville, MD
Tetracore, Inc.
UEI V7HKYLEP7N37, CAGE 1XSU3
1 award and $0 obligated between July 29, 2026 and July 29, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024C00073Definitive Contract, July 29, 2026, Full and Open Competition After Exclusion of Sources, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Phase II Development of Rapid Molecular Assay for Point of Care Detection of Treponema PallidumNAICS 541714, PSC AN12 | $0 |
- Places of performance
- Maryland
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards